开发下一代内源性OCT4诱导剂及其体内抗衰老作用
Han Kang1, Sebastian Hasselbeck2, Katerina Taškova3
1Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Germany.
European journal of medicinal chemistry
|May 30, 2023
概括
研究人员发现了新的小分子,O4I,诱导OCT4,一个关键的多能性因子. 这使得在没有外源性OCT4的情况下能够产生临床级人类诱导多能干细胞 (iPSC),在再生医学中具有潜在的应用.
科学领域:
- 干细胞生物学 干细胞生物学
- 化学生物学 化学生物学
- 再生医学是一种再生医学.
背景情况:
- 生产人类诱导多能干细胞 (iPSCs) 通常需要转录因子,如OCT4,但外源表达可能会损害发育潜力.
- 识别诱导内源性OCT4的小分子对于创建临床级的iPSC至关重要.
研究的目的:
- 发现和开发能够诱导内源性OCT4表达的小分子.
- 在不依赖外源性OCT4输送的情况下产生稳定和真实的多能干细胞.
主要方法:
- 进行了基于细胞的高通量选,以确定OCT4诱导化合物 (O4I).
- 合成了代谢稳定的类似物,如O4I4.4.
- 结合O4I4与转录因子尾酒 (SOX2,KLF4,MYC,LIN28 - CSKML) 用于重新编程人类纤维细胞.
主要成果:
- 发现了新的O4I,包括稳定的模拟O4I4,可激活内源性OCT4和相关信号通路.
- 通过使用O4I4和CSKML尾酒,成功地将人类纤维细胞重新编程成稳定,真实的多能状态,从而消除了对外源性OCT4.4的需求.
- 在Caenorhabditis elegans和Drosophila中,O4I4证明了寿命延长.
结论:
- O4I,特别是O4I4,通过使内源性OCT4诱导成为可能,在iPSC生成方面取得了重大进展.
- 这种方法促进了临床级iPSC的产生,克服了与外源性OCT4表达相关的局限性.
- 由于其延长寿命的作用,O4I4在再生医学和抗衰老疗法中的应用具有前景.
相关概念视频
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Methods of Nuclear Reprogramming
1.9K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K
Induced Pluripotent Stem Cells
4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.2K
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Tissue Renewal without Stem Cells
1.8K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
1.8K


